echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Establishment of new drug R & D cooperation agreement between Sihuan pharmaceutical and to BBB

    Establishment of new drug R & D cooperation agreement between Sihuan pharmaceutical and to BBB

    • Last Update: 2020-04-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Sihuan pharmaceutical holding group (00460) announced that its wholly-owned subsidiary Yaozhong International (Hong Kong) and to-bbb technologies B.V entered into a cooperation agreement today on several cooperation arrangements with the group for research and development of new drugs, combining the group's innovative drug compounds with g-technology of to-bbb for feasibility study By entering into a cooperation agreement, the group aims to benefit from unmet high-end medical needs by rapidly penetrating blood-brain barrier drugs The cooperation to be carried out under the cooperation agreement will invest the research efforts of to BBB brain targeting technology and the group's R & D resources in the field of tumor and central nervous system The group will take this opportunity to cooperate with internationally renowned brain drug delivery technology developers and be able to rely on the joint efforts to further develop the use of various pharmaceutical compounds of the group Headquartered in Leiden, the Netherlands, to BBB is a company mainly engaged in the development of brain drug delivery technology and products, and has obtained the global exclusive patent for the development and operation of g-technology brain drug delivery technology.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.